EUVIMEDOdkrijte EUVIMED
Open access · CC BY 4.0

ARAP3 protects from excessive formylated peptide‐induced microvascular leakage by acting on endothelial cells and neutrophils

Julia Y Chu, Barry McCormick, Kruthika Sundaram, Gareth Hardisty, Utsa Karmakar, Caroline Pumpe, Elizabeth Krull, Christopher D Lucas iD, Joana Amado-Azevedo, Peter L Hordijk, Andrea Caporali, Harry Mellor and 3 more

The Journal of Pathology · 2024

DOI: 10.1002/path.6288 ↗

At a glance

Journal article in The Journal of Pathology, 2024. Written by Julia Y Chu and 14 co-authors. Institution: Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK. Major MEDLINE topics: Capillary Permeability, Endothelial Cells, GTPase-Activating Proteins, Neutrophils. Cited 2 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical Research Council, Versus Arthritis, British Heart Foundation.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Vascular permeability is temporarily heightened during inflammation, but excessive inflammation‐associated microvascular leakage can be detrimental, as evidenced in the inflamed lung. Formylated peptides regulate vascular leakage indirectly via formylated peptide receptor‐1 (FPR1)‐mediated recruitment and activation of neutrophils. Here we identify how the GTPase‐activating protein ARAP3 protects against formylated peptide‐induced microvascular permeability via endothelial cells and neutrophils. In vitro , Arap3 −/− endothelial monolayers were characterised by enhanced formylated peptide‐induced permeability due to upregulated endothelial FPR1 and enhanced vascular endothelial cadherin internalisation. In vivo , enhanced inflammation‐associated microvascular leakage was observed in Arap3 −/− mice. Leakage of plasma protein into the lungs of Arap3 −/− mice increased within hours of formylated peptide administration. Adoptive transfer experiments indicated this was dependent upon ARAP3 deficiency in both immune and non‐immune cells. Bronchoalveolar lavages of formylated peptide‐challenged Arap3 −/− mice contained neutrophil extracellular traps (NETs). Pharmacological inhibition of NET formation abrogated excessive microvascular leakage, indicating a critical function of NETs in this context. The observation that Arap3 −/− mice developed more severe influenza suggests these findings are pertinent to pathological situations characterised by abundant formylated peptides. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Capillary PermeabilityEndothelial CellsGTPase-Activating ProteinsNeutrophilsAnimalsHumansMiceAdaptor Proteins, Signal TransducingExtracellular TrapsLungMice, Inbred C57BLMice, Knockout

Author keywords

ARAP3FPR1GTPase activating proteinNETVE‐cadherincapillaryendothelial cellendothelial permeabilityfMLFformylated peptideslungneutrophilneutrophil extracellular trapvascular leakage

Substances

Adaptor Proteins, Signal TransducingARAP3 protein, mouseGTPase-Activating ProteinsARAP3 protein, human

Authors and institutions

  • Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.
  • Department of Physiology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh, UK.
  • School of Biochemistry, University of Bristol, Bristol, UK.
  • The Roslin Institute, University of Edinburgh, Edinburgh, UK.

ORCID profiles: Christopher D Lucas, Sonja Vermeren

Funding

  • Medical Research Council
  • Versus Arthritis
  • British Heart Foundation

Cite

APA

Chu, J. Y., McCormick, B., Sundaram, K., Hardisty, G., Karmakar, U., Pumpe, C., Krull, E., Lucas, C. D., Amado-Azevedo, J., Hordijk, P. L., Caporali, A., Mellor, H., Baillie, J. K., Rossi, A. G., & Vermeren, S. (2024). ARAP3 protects from excessive formylated peptide‐induced microvascular leakage by acting on endothelial cells and neutrophils. The Journal of Pathology. https://doi.org/10.1002/path.6288

Vancouver

Chu JY, McCormick B, Sundaram K, Hardisty G, Karmakar U, Pumpe C, et al. ARAP3 protects from excessive formylated peptide‐induced microvascular leakage by acting on endothelial cells and neutrophils. The Journal of Pathology. 2024. doi:10.1002/path.6288

BibTeX
@article{Chu2024,
  author = {Chu, Julia Y and McCormick, Barry and Sundaram, Kruthika and Hardisty, Gareth and Karmakar, Utsa and Pumpe, Caroline and Krull, Elizabeth and Lucas, Christopher D and Amado-Azevedo, Joana and Hordijk, Peter L and Caporali, Andrea and Mellor, Harry and Baillie, J Kenneth and Rossi, Adriano G and Vermeren, Sonja},
  title = {ARAP3 protects from excessive formylated peptide‐induced microvascular leakage by acting on endothelial cells and neutrophils},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6288}
}
Start for free →